ENDRA Life Sciences Inc. (NDRA) Stock Profile — Insider Trades & Financials

EPS$-5.68

Market Cap$6.4M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Alexander Tokman

CEO & Executive Director

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Founded: 2007
Employees: 21
Headquarters: Ann Arbor, Michigan, United States

⚡

Core Efficiency

D/E Ratio?

0.71

📊

Profitability Ratios

Current Ratio?

1.29

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Sep 25, 2026 (in 169 days)

Annual Report (10-K) — Based on filing pattern

Sep 25, 2026

Predicted10-K

Mar 31, 2026

10-KQ4 20250d after period end

Mar 31, 2026

10-KFY 202590d after period end

Nov 14, 2025

10-QQ3 20250d after period end

Aug 14, 2025

10-QQ2 20250d after period end

May 15, 2025

10-QQ1 20250d after period end

Apr 7, 2025

10-K/AQ4 202414d after period end

Mar 31, 2025

10-KFY 202590d after period end

Nov 21, 2024

10-Q/AQ3 20242d after period end

Loading company sections...

ENDRA Life Sciences Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness